Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Monthly Subcutaneous Administration of Tonlamarsen in Participants With Uncontrolled Hypertension (KARDINAL)

NCT06864104 is registered in ClinicalTrials.gov with Kardigan, Inc. as lead sponsor.

NCT NCT06864104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06864104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Monthly Subcutaneous Administration of Tonlamarsen in Participants With Uncontrolled Hypertension (KARDINAL)
Lead sponsor
Kardigan, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2025
Completion date
March 17, 2026
Enrollment
206 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension